LEXX - Lexaria Bioscience Corp logo

Lexaria Bioscience Corp

LEXX

Lexaria Bioscience Corp develops DehydraTECH, a patented drug delivery technology that enhances the absorption of active pharmaceutical ingredients using long-chain fatty acids. Its applications span various therapeutic areas and product formats, including pharmaceuticals and nutraceuticals.

βš•οΈ Healthcare NASDAQ Listed 2006 $ USD
$1,000 invested 5 years ago β†’$28today

Score Overview

1 Year
Score
Net Growth19.93%
Net TrendGrew
Net Income Consistencyβ€”
Rev Growth-47.87%
Rev TrendShrank
Revenue Consistencyβ€”
5 Years
Score3.7
Net Growth-136.65%
Net Trend60%
Net Income Consistencyβ€”
Rev Growth-49.08%
Rev Trend40%
Revenue Consistencyβ€”
10 Years
Score
Net Growth-5x
Net Trend50%
Net Income Consistency
Rev Growth9x
Rev Trend60%
Revenue Consistency
20 Years
Scoreβ€”
Net Growthβ€”
Net Trendβ€”
Net Income Consistency
Rev Growthβ€”
Rev Trendβ€”
Revenue Consistency
All Time
Score
Net Growth-7x
Net Trend58%
Net Income Consistency
Rev Growth-59.15%
Rev Trend47%
Revenue Consistency

Explore the 2021 public Archive ranking β†’

Where Lexaria Bioscience Corp has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • LEXX

2018: 92.7% Β· 2021: 97.2% Β· free through 2021 Β· longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-21
$ 2.82β€”
1 Year2025-10-21
$ 13.61-79.27%
5 Years2021-10-21
$ 101.70-97.23%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 368K-$ 9M$ 5M
2025$ 705.92K-$ 11M$ 1M
2024$ 464.28K-$ 5M$ 6M
2023$ 226.21K-$ 6M$ 1M
2022$ 255.4K-$ 7M$ 6M
2021$ 722.74K-$ 4M$ 11M
2020$ 314.79K-$ 3M$ 1M
2019$ 222.61K-$ 4M$ 1M
2018$ 433.29K-$ 6M$ 1M
2017$ 63.64K-$ 1M$ 2M
2016$ 40.72K-$ 1M$ 93.41K
2015$ 14.7K-$ 1M$ 260.07K
2014$ 1M-$ 1M$ 65.54K
2013$ 1M-$ 343.55K$ 65.54K
2012$ 1M-$ 343.55K$ 27.53K
2011$ 1M-$ 251.51K$ 31.2K
2010$ 1M-$ 538.23K$ 494.44K
2009$ 362.47K-$ 552.46K$ 431.39K
2008$ 421.95K-$ 753.57K$ 239.66K
2007$ 900.79K-$ 978.49K$ 78.06K
LEXX - Lexaria Bioscience Corp logo

Lexaria Bioscience Corp fundamental performance

Between 2020 and 2025, revenue grew from $ 314.79K to $ 705.92K and net income went from -$ 3M to -$ 11M. Revenue increased in 2 of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 14.7K to $ 705.92K and net income went from -$ 1M to -$ 11M. Revenue increased in 6 of those 10 years; net income in 5.

Lexaria Bioscience Corp currently holds a 5-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.

Membership

Continue LEXX’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,118 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year Β· Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies